Larimar Therapeutics
levels determine disease progression in sis years | Larimar Therapeutics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
7 of 44
Related slides by other companies
NeuroSense Therapeutics
Investor Presentation
October 2024
summary of paradigm phase results | NeuroSense Therapeutics
Aeglea BioTherapeutics
Investor Presentation
April 2023
| Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
May 2023
| Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
March 2023
| Aeglea BioTherapeutics
Other recent decks by Larimar Therapeutics
See all presentations (3 decks)
Results
November 2022
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights